Click a link below to view the mailing archive as if it had been sent to you.
| 2025-07-31 23:24 | | Merck will lay off 6,000, reducing workforce by 8% in cost-cutting purge and more... |
| 2025-07-31 12:34 | | Moderna to slash 10% of workforce as biotech cuts costs, Covid shot sales slow and more... |
| 2025-07-31 12:30 | | Takeda wades through more Vyvanse declines, muses DTC model as US pricing uncertainty looms and more... |
| 2025-07-30 12:05 | | Takeda wades through more Vyvanse declines, muses DTC model as US pricing uncertainty looms and more... |
| 2025-07-29 22:42 | | Lilly set for strong quarter after Novo profit warning and more... |
| 2025-07-29 12:17 | | Novo Nordisk names new CEO as the obesity drugmaker cuts sales, profit outlook and more... |
| 2025-07-28 23:35 | | FDA takes U-turn on Sarepta's Elevidys and more... |
| 2025-07-28 12:03 | | Novo Nordisk faces 'show me' moment to boost Wegovy growth after US copycat ban and more... |
| 2025-07-25 12:07 | | Sun Pharma, Taro agree to $200M settlement in generics price-fixing litigation and more... |
| 2025-07-24 21:32 | | Eli Lilly (LLY) Collaborates With Gate Bioscience For Innovative Molecular Gate Therapeutics and more... |
| 2025-07-24 12:11 | | AstraZeneca drug acquired in Alexion deal succeeds in autoimmune disease trial and more... |
| 2025-07-23 23:04 | | Lawmakers introduce bill to end drugmaker limits on 340B discounts and more... |
| 2025-07-23 12:15 | | FDA opens pilot run of commissioner voucher program and more... |
| 2025-07-22 23:18 | | AbbVie wins $56M royalty award from Revance in Botox patent infringement case and more... |
| 2025-07-22 12:14 | | Sanofi buys UK biotech company to expand respiratory vaccine portfolio and more... |
| 2025-07-21 23:00 | | Sarepta stops Elevidys shipments after standoff with FDA and more... |
| 2025-07-21 11:17 | | Lack of US data stymies Roche's earlier-stage lymphoma push for Columvi and more... |
| 2025-07-20 23:15 | | Gene therapy maker Sarepta tells FDA it won't halt shipments despite patient deaths and more... |
| 2025-07-18 12:12 | | What's on neurologists' minds? Not drug names, survey shows, and more... |
| 2025-07-17 22:21 | | Biotech startup funding dried up in second quarter, and more... |
| 2025-07-17 12:08 | | Personalized spine surgery developer Carlsmed plots $100M-plus IPO and more... |
| 2025-07-16 22:58 | | Personalized spine surgery developer Carlsmed plots $100M-plus IPO and more... |
| 2025-07-16 12:30 | | J&J flexes $15B quarter for innovative drugs as biosimilars and more... |
| 2025-07-15 12:11 | | China biotechs reshaping US biopharma and more... |
| 2025-07-14 22:46 | | CP Daily News - July 14 2025 |
| 2025-07-11 12:15 | | Karyopharm lays off more workers as hunt for strategic alternatives turns up short and more... |
| 2025-07-11 00:15 | | FDA approves Moderna COVID vaccine for kids under 12 at higher risk and more... |
| 2025-07-10 12:15 | | AbbVie pays $700M upfront for trispecific rival to J&J, Pfizer in blood cancer and more... |
| 2025-07-10 00:15 | | Biopharma layoffs for first half of the year jump 32% YOY and more... |
| 2025-07-09 12:15 | | Pfizer’s Sally Susman to step down at year’s end amid broader restructuring and more... |
| 2025-07-09 00:15 | | The Stelara Biosimilar Price War: How PBM-Affiliated Private Labels Are Reshaping the Market and more... |
| 2025-07-08 12:15 | | ALS community petitions FDA to reconsider Brainstorm’s NurOwn, pointing to recent survival data and more... |
| 2025-07-08 00:15 | | Medical groups, pregnant doctor sue RFK Jr. over vaccine changes and more... |
| 2025-07-07 12:15 | | Baxter taps a new CEO as it emerges from years-long restructuring and more... |
| 2025-07-03 12:15 | | Summit said to be in talks with Astra to license potential rival for Merck’s Keytruda and more... |
| 2025-07-03 00:15 | | Bluebird go-private deal signals the ‘PE-ization of pharma’ and more... |
| 2025-07-02 12:15 | | Regeneron’s linvoseltamab receives FDA approval for multiple myeloma and more... |
| 2025-07-02 00:15 | | Protagonist enters obesity fray with triple-G pill, eyeing 2026 clinical start and more... |
| 2025-07-01 12:15 | | AstraZeneca CEO considers moving company listing to US, the Times reports and more... |
| 2025-07-01 00:15 | | Calico inks $596m deal for drugs targeting longevity-linked cytokine and more... |
